Gary Dunetz, MD
Urology · Nashua, NHNPI 1265528640
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 25.6% of the total. Reporting peaked in 2022 at $314 and has fallen 72.2% since, to $87 in 2024. That places this record below the midpoint for urology clinicians in NH, where the typical reported total is $863.
Across 32 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$171
- Boston Scientific$86
- Teleflex LLC$56
- Endo Pharmaceuticals Inc.$53
- Astellas Pharma US Inc$40
- Myriad Genetic Laboratories, Inc.$32
- plus $228 from 10 others
What the payments were for
- Food & beverage$666100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $171 |
| Boston Scientific | 4 | $86 |
| Teleflex LLC | 2 | $56 |
| Endo Pharmaceuticals Inc. | 3 | $53 |
| Astellas Pharma US Inc | 2 | $40 |
| Myriad Genetic Laboratories, Inc. | 2 | $32 |
| Bayer | 1 | $27 |
| Progenics Pharmaceuticals, Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Coloplast | 2 | $26 |
| Cook Medical LLC | 1 | $24 |
| Myovant Sciences Inc. | 1 | $24 |
| Urogen Pharma, Inc. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Urovant Sciences Inc | 1 | $17 |
| Blue Earth Diagnostics | 1 | $16 |
How this compares
$666 in reported general payments places this provider in the 45th percentile of 61 urology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Thiola EcTiopronin | 11 | $85,717 |
| MyrbetriqMirabegron | 51 | $52,080 |
| GemtesaVibegron | 47 | $40,972 |
| Tamsulosin Hcl | 728 | $14,345 |
| Finasteride | 662 | $7,993 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 320 | $6,615 |
| Methenamine Hippurate | 66 | $4,968 |
| Tolterodine Tartrate ErTolterodine Tartrate | 45 | $4,834 |
| Mirabegron ErMirabegron | 15 | $4,590 |
| Silodosin | 37 | $3,380 |
| Testosterone | 18 | $2,265 |
| Oxybutynin Chloride ErOxybutynin Chloride | 66 | $1,688 |
| NitrofurantoinNitrofurantoin Macrocrystal | 15 | $1,354 |
| Trospium Chloride | 12 | $969 |
| Estradiol | 14 | $793 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $40 | $52,08051 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $26 | $40,97247 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 61 urology providers in New Hampshire.
Other urology in Nashua
- Matthew JohnsonNashua$6K
- Miguel AnteloNashua$4K
- Vassili GlazyrineNashua$3K
- Stephen HillNashua$1K
- Matthew StanizziNashua$79
- Martin GrossKeene$172K
- Ramiro Madden-FuentesConcord$82K
- Jason AkermanManchester$53K
- Lori LernerLebanon$49K
- E William JohnsonExeter$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.